Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They are focused on delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients.